Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 355 · FDA Modernization Act 3.0 ·

Passed the Senate · step 3 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 355 New drugs

Couldn't place the change
More for 21 U.S.C. § 355
Read § 355Only this section

The bill's words for this section

  1. Not carried out:

    Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by designating the second subsection (z) (relating to clinical trial diversity action plans), as added by section 3601(a) of the Health Extenders, Improving Access to Medicare, Medicaid, and CHIP, and Strengthening Public Health Act of 2022 (division FF of Public Law 117–328), as subsection (aa).

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: designating the second subsection (X) (relating to clinical trial diversity action plans), as added by section N (X) of the health extenders, improving access to medicare, medicaid, and chip, and strengthening public health act of N (division ff of REF), as subsection (X).

Step through the changes